Transulnar Access in Patients With Ipsilateral Radial Artery Occlusion Undergoing Coronary Angiography or Angioplasty
ULNART
1 other identifier
observational
127
1 country
2
Brief Summary
Coronary angiography and angioplasty are commonly performed through the radial artery at the wrist as this approach is associated with fewer bleeding complications and faster recovery. In some patients, the radial artery becomes occluded after prior procedures, requiring selection of an alternative access site for future coronary interventions. The ulnar artery is a potential alternative wrist access. However, limited data are available on the safety of using the ulnar artery in the same arm as an occluded radial artery and on the possible effects on hand strength, sensation, and daily hand function. The goal of this observational study is to evaluate the safety of transulnar access and its effect on hand function in adults with ipsilateral radial artery occlusion undergoing coronary angiography or angioplasty. The main questions addressed by the study are:
- How often do serious access-related vascular or nerve complications occur?
- Does hand strength, sensation, or functional use of the hand change during follow-up?
- Does the ulnar artery remain patent after the procedure? The choice of vascular access site is made by the treating physician based on clinical judgment. Participants who undergo transulnar access will undergo follow-up assessments, including ultrasound evaluation of arm arteries, standardized hand function testing, and short questionnaires assessing upper-limb function. The findings of this study are expected to inform access-site selection, improve patient counseling, and support safer care for patients with radial artery occlusion undergoing coronary procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2025
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2025
CompletedFirst Submitted
Initial submission to the registry
January 21, 2026
CompletedFirst Posted
Study publicly available on registry
February 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2032
February 2, 2026
January 1, 2026
4.2 years
January 21, 2026
January 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Serious Access-Related Vascular and Clinical Neuromuscular Complications
Composite incidence of serious vascular and clinical neuromuscular complications attributable to transulnar arterial access ipsilateral to radial artery occlusion. Serious vascular events include acute hand ischemia, symptomatic ulnar artery occlusion, flow-limiting dissection requiring treatment, pseudoaneurysm or arteriovenous fistula requiring intervention, major access-site hematoma, or major bleeding. Clinical neuromuscular events include new, clinically evident motor or sensory deficits in the ulnar nerve distribution that persist or require targeted therapy.
30 days
Secondary Outcomes (10)
Number of Access Attempts
During the index procedure
Technical Success Without Access-Site Crossover
During the index procedure
Procedure Duration
During the index procedure
Ulnar Artery Patency
Within 24 hours, 30 days, and 180 days
Early Access-Related Vascular and Neuromuscular Complications
Within 24 hours after band removal
- +5 more secondary outcomes
Study Arms (1)
ULNART Cohort
Adults with documented radial artery occlusion undergoing elective coronary angiography or angioplasty, in whom transulnar arterial access ipsilateral to the occluded radial artery is selected by the treating physician. Participants are followed prospectively to assess vascular safety and hand function outcomes.
Eligibility Criteria
Participants are recruited from cardiac catheterization laboratories and cardiology services of two tertiary-care public hospitals in Greece, including high-volume referral centers performing invasive coronary procedures. The study population represents adults undergoing routine elective coronary angiography or angioplasty in these hospital settings, where vascular access decisions are made as part of standard clinical practice.
You may qualify if:
- Participants must meet all of the following criteria to be eligible:
- Adults aged 18 years or older
- Documented radial artery occlusion in the upper limb intended for vascular access, confirmed by ultrasound or angiography
- Scheduled to undergo elective coronary angiography and/or angioplasty
- Transulnar arterial access on the same side as the occluded radial artery is selected by the treating physician
- Contralateral radial artery access is not feasible or is clinically undesirable, including for reasons such as:
- documented occlusion or severe disease of the contralateral radial artery
- unfavorable anatomy or prior failed access
- strategic preservation of the contralateral radial artery for future surgical or dialysis needs
- Adequate ulnar artery flow and anatomy for access, as assessed by pre-procedural ultrasound
- Able and willing to provide written informed consent
You may not qualify if:
- Participants meeting any of the following criteria will be excluded:
- Inadequate or absent ulnar artery flow at the intended access site on ultrasound
- Known ulnar nerve injury or neuropathy affecting the access-side upper limb
- Severe pre-existing motor or sensory dysfunction of the access-side hand that would interfere with functional assessment
- Emergency coronary procedures that preclude baseline vascular or functional assessment
- Participation in another interventional clinical study involving vascular access or intervention in the same upper limb
- Local conditions at the intended access site, such as active infection, burn, or extensive scarring
- Pregnancy or breastfeeding
- Life expectancy less than 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hellenic Red Cross Hospital
Athens, Greece
Hippokratio General Hospital
Athens, Greece
Related Publications (10)
Roghani-Dehkordi F, Hosseinzadeh H, Kermani-Alghoraishi M, Khosravi A, Vakhshoori M, Sadeghi M, Danesh M, Sadeghi N, Sahfie D. The transulnar approach in the patients with ipsilateral radial artery occlusion. ARYA Atheroscler. 2020 Jan;16(1):33-38. doi: 10.22122/arya.v16i1.2016.
PMID: 32499829BACKGROUNDHsueh SK, Cheng CI, Fang HY, Omran MM, Liu WH, Chung WJ, Chen CJ, Yang CH, Fang CY, Wu CJ. Feasibility and Safety of Transulnar Catheterization in Ipsilateral Radial Artery Occlusion. Int Heart J. 2017 May 31;58(3):313-319. doi: 10.1536/ihj.16-244. Epub 2017 May 12.
PMID: 28496021BACKGROUNDKedev S, Zafirovska B, Dharma S, Petkoska D. Safety and feasibility of transulnar catheterization when ipsilateral radial access is not available. Catheter Cardiovasc Interv. 2014 Jan 1;83(1):E51-60. doi: 10.1002/ccd.25123. Epub 2013 Aug 5.
PMID: 23832623BACKGROUNDDuarte PVF, Cortes LA, de Almeida Sampaio FB, Barroso JM, da Silveira GM, Nascif GB, Filho AO, Ribeiro ML, Salles MM, De Lorenzo A. Feasibility and Safety of Ipsilateral Ulnar Access in Cases of Impossibility or Failure of Radial Access for Coronary Angiography or Percutaneous Coronary Intervention. J Invasive Cardiol. 2022 Feb;34(2):E92-E97. doi: 10.25270/jic/21.00138. Epub 2022 Jan 16.
PMID: 35037897BACKGROUNDBernat I, Aminian A, Pancholy S, Mamas M, Gaudino M, Nolan J, Gilchrist IC, Saito S, Hahalis GN, Ziakas A, Louvard Y, Montalescot G, Sgueglia GA, van Leeuwen MAH, Babunashvili AM, Valgimigli M, Rao SV, Bertrand OF; RAO International Group. Best Practices for the Prevention of Radial Artery Occlusion After Transradial Diagnostic Angiography and Intervention: An International Consensus Paper. JACC Cardiovasc Interv. 2019 Nov 25;12(22):2235-2246. doi: 10.1016/j.jcin.2019.07.043.
PMID: 31753298BACKGROUNDHahalis G, Aznaouridis K, Tsigkas G, Davlouros P, Xanthopoulou I, Koutsogiannis N, Koniari I, Leopoulou M, Costerousse O, Tousoulis D, Bertrand OF. Radial Artery and Ulnar Artery Occlusions Following Coronary Procedures and the Impact of Anticoagulation: ARTEMIS (Radial and Ulnar ARTEry Occlusion Meta-AnalysIS) Systematic Review and Meta-Analysis. J Am Heart Assoc. 2017 Aug 23;6(8):e005430. doi: 10.1161/JAHA.116.005430.
PMID: 28838915BACKGROUNDSgueglia GA, Hassan A, Harb S, Ford TJ, Koliastasis L, Milkas A, Zappi DM, Navarro Lecaro A, Ionescu E, Rankin S, Said CF, Kuiper B, Kiemeneij F. International Hand Function Study Following Distal Radial Access: The RATATOUILLE Study. JACC Cardiovasc Interv. 2022 Jun 27;15(12):1205-1215. doi: 10.1016/j.jcin.2022.04.023. Epub 2022 May 17.
PMID: 35595672BACKGROUNDZwaan EM, Cheung ES, IJsselmuiden AJJ, Holtzer CAJ, Schreuders TAR, Kofflard MJM, Coert JH. Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial. J Interv Cardiol. 2022 Sep 6;2022:6858962. doi: 10.1155/2022/6858962. eCollection 2022.
PMID: 36128073BACKGROUNDValgimigli M, Campo G, Penzo C, Tebaldi M, Biscaglia S, Ferrari R; RADAR Investigators. Transradial coronary catheterization and intervention across the whole spectrum of Allen test results. J Am Coll Cardiol. 2014 May 13;63(18):1833-41. doi: 10.1016/j.jacc.2013.12.043. Epub 2014 Feb 26.
PMID: 24583305BACKGROUNDKolkailah AA, Alreshq RS, Muhammed AM, Zahran ME, Anas El-Wegoud M, Nabhan AF. Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in people with coronary artery disease. Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD012318. doi: 10.1002/14651858.CD012318.pub2.
PMID: 29665617BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Konstantinos Aznaouridis, Ass. Professor of Cardiology
1st Department of Cardiology, Hippokration Hospital, National and Kapodistrian University of Athens
- PRINCIPAL INVESTIGATOR
Dimitrios Karelas, MD
National and Kapodistrian University of Athens
- PRINCIPAL INVESTIGATOR
Ioannis Tsiafoutis, MD, PhD
2nd Department of Cardiology, Hellenic Red Cross Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 21, 2026
First Posted
February 2, 2026
Study Start
November 1, 2025
Primary Completion (Estimated)
January 1, 2030
Study Completion (Estimated)
January 1, 2032
Last Updated
February 2, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
De-identified individual participant data that underlie the results reported in publications arising from this study will be made available, including demographic variables, procedural characteristics, vascular imaging findings, functional test results, and patient-reported outcome measures. A corresponding data dictionary and study protocol will be provided. Data will be shared after publication of the primary results, upon reasonable request, subject to approval by the study investigators and completion of a data-use agreement, in accordance with applicable ethical approvals and data protection regulations.